Compounded Bi-Mix intracavernosal injection (ICI) prepared per prescriber direction for individualized erectile dysfunction care planning. Prescription required.
Bi-Mix is a compounded intracavernosal injection (ICI) formulation prepared by HDRx according to individualized prescriber specifications. It contains a combination of Prostaglandin E1 and Phentolamine. A valid prescription from a licensed healthcare provider is required.
This injectable formulation may be incorporated into provider-directed erectile dysfunction (ED) care plans when clinically appropriate. Compounding allows healthcare providers to tailor ingredient concentration and dosing parameters based on individual patient response and clinical judgment.
HDRx collaborates with urology and men’s health providers to prepare customized injectable options within structured care planning. Learn more about erectile dysfunction support on our Erectile Dysfunction page, our broader Men’s Health services, and educational discussions involving Bi-Mix, Tri-Mix, Quad-Mix, and tadalafil in ED care planning, as well as our overview of urology compounding services.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs. Patients should consult their licensed healthcare provider to determine whether this formulation is appropriate for their individual care plan.
